Professional Documents
Culture Documents
Genetically Engineered Plants and Crops: Definitions: Genetic Modification
Genetically Engineered Plants and Crops: Definitions: Genetic Modification
years a lateral transfer of genes among more or less related species, which has ended up in the
present high proportion of Similarity among the genomes of plants and of animals belonging to
the same families or rather distant groups (e.g. the genomes of humans and apes, but also mouse
and even yeast).
Some examples of genetic engineering are the incorporation of genes for insecticidal
proteins of Bacillus thuringiensis (Bt) into the genomes of several crop species such as
tobacco, maize, potato, rice, cotton, etc.; genes for the synthesis of beta-carotene from daffodil
and a bacterium into rice ("golden rice"; Ye et aI., 2000); genes for human haemoglobin into
tobacco plants; genes for human milk proteins into rice; genes for the hepatitis B surface
antigen (HbsAg) into a yeast (Pichia), etc.
Genetic engineering does not necessarily consist of transferring one or more genes to a
crop species or variety. It can aim at inhibiting the expression of a gene through producing
an anti-sense messenger RNA of this gene . In fact, the first transgenic plant product to
reach the market in 1996 was a tomato produced by the US company Calgene, Inc., whose
polygalacturonase (an enzyme that softens the fruit during ripening) gene has been repressed
by an anti-sense RNA. Labelled tomato paste made from genetically engineered tomato by
Zeneca pIc had captured 60 per cent of market share, i.e . consumers liked it. But in 1999,
the British supermarkets withdrew it from their shelves, because they feared a boycott of
their conventional products by the consumers' associations which denounced foodstuffs
derived from transgenic crops as "Frankenstein" food.
activity that led to the production of purple pigment. Other scientists then found microRNAs
in primitive animals and in humans. The micro RNA attaches to the messenger RNA and
destroys it before it can produce its designated protein, thus interfering with or "silencing"
the instructions of the gene (Komaroff and Lieberman, 2005).
Considered just a curiosity at first, RNA interference has since revolutionized biological
research. It allows scientists to silence specific genes very precisely in cell cultures and even
in organisms. It is easy enough to produce microRNAs that silence a particular gene. Such
synthetically made RNAs are called small interfering RNAs, or siRNAs. Progress is being made
on the best ways to deliver siRNA into the organism. While the value of RNA interference
in new breeding processes of crops remains to be proved, the story of its discovery is the
latest example of how an investment in basic research can lead to completely unexpected,
and enormously beneficial, results (Komaroff and Lieberman, 2005).
In 1995, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) of
Australia first demonstrated gene silencing in an organism by intentionally using double-
stranded RNA. The CSIRO has filed a number of patent applications relating to the gene-
silencing area and holds a United States-granted patent (US 6,423,885 "Methods for obtaining
modified phenotypes in plant cells")' an accepted patent application in Australia and other
international applications. The United States and United Kingdom patent offices announced a
grant of patent on applications filed by Benitec Australia Ltd and the Queensland Department
of Primary Industries in relation to certain gene silencing applications in animals, as well as
by Syngenta (the agrochemical giant corporation created by the merger of the agrochemical
divisions of Novartis and AstraZeneca) and the Carnegie Institute. The CSIRO opposed the
Australian patent applications on the grounds that it was the rightful owner of this technology
and has submitted extensive documentary evidence to the Australian Patent Office asserting
that the technology had already been invented and refined by CSIRO scientists prior to mid-
1996.